Real-time enrollment status for this growth hormone deficiency clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:07 PM UTC
| NCT Number | NCT05820672 |
| Recruiting Status | Recruiting |
| Condition | Growth Hormone Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 900 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Ascendis Pharma Endocrinology Division A/S |
| Last Updated on CT.gov | April 21, 2026 (Apr 21, 2026) |
As of July 13, 2026: Clinical trial NCT05820672 is currently recruiting participants. This clinical trial study for growth hormone deficiency is actively seeking new participants at 27 locations across the United States. The study is sponsored by Ascendis Pharma Endocrinology Division A/S. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05820672 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05820672 was last updated Apr 21, 2026 (April 21, 2026). HelloStudys verifies this status automatically.